Severe persistent visual field constriction associated with vigabatrin: asymptomatic as well as symptomatic defects occur with vigabatrin

R. Mackenzie*, A. Klistorner

*Corresponding author for this work

    Research output: Contribution to journalComment/opinionpeer-review

    53 Citations (Scopus)

    Abstract

    Editor—Since Eke et al's report of sympto­matic visual field defects in three patients taking vigabatrin, a drug surveillance database at Hoechst Marion Roussel had identified another 92 cases by June 1997. Asymptomatic visual field defects may be
    more common, but the exact incidence is unknown and data on the results of field
    testing and electrophysiology are lacking in this group. We report these results in two asymptomatic patients.
    Original languageEnglish
    Pages (from-to)233
    Number of pages1
    JournalBMJ (Clinical research ed.)
    Volume316
    Issue number7126
    Publication statusPublished - 1998

    Fingerprint

    Dive into the research topics of 'Severe persistent visual field constriction associated with vigabatrin: asymptomatic as well as symptomatic defects occur with vigabatrin'. Together they form a unique fingerprint.

    Cite this